Momordica charantia seed extract reduces pre-adipocyte viability, affects lactate dehydrogenase release, and lipid accumulation in 3T3-L1 cells

Journal of Medicinal Food

Volumn 14, Issue 3, 2011, Pages 201-208

  Popovich, David G ^a   Lee, Yiyu ^a   Li, Lu ^a   Zhang, Wei ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

3T3 L1 cells; adipogenesis; bitter melon; Momordica charantia seed; saponins; triterpenoids

Indexed keywords

LACTATE DEHYDROGENASE; LIPID; METHANOL; MOMORDICA CHARANTIA EXTRACT; TRIACYLGLYCEROL;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN 3T3; CELL VIABILITY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ENZYME RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID STORAGE; MOMORDICA CHARANTIA; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; PROADIPOCYTE; SOLVENT EXTRACTION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL SURVIVAL; L-LACTATE DEHYDROGENASE; LIPID METABOLISM; MICE; MOMORDICA CHARANTIA; PLANT EXTRACTS; SEEDS; TRITERPENES;

CUCUMIS; MOMORDICA CHARANTIA;

EID: 79951988610     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2010.1150     Document Type: Article

References (45)

1. Grover JK, Yadav S, Vats V: Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 2002;81:81-100. (Pubitemid 34518472)
2. Mentreddy SR: Review - medicinal plant species with potential antidiabetic properties. J Sci Food Agric 2007;87:743-750.
3. Pieroni A, Houlihan L, Ansari N, Hussain B, Aslam S: Medicinal perceptions of vegetables traditionally consumed by South-Asian migrants living in Bradford, Northern England. J Ethnopharmacol 2007;113:100-110. (Pubitemid 47079164)
4. Grover JK, Yadav SP: Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol 2004;93:123-132. (Pubitemid 38739282)
5. Raman A, Lau C: Anti-diabetic properties and phytochemistry of Momordica charantia L (Cucurbitaceae). Phytomedicine 1996;2:349-362.
6. Wu SJ, Ng LT: Antioxidant and free radical scavenging activities of wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) in Taiwan. Lebenson Wiss Technol 2008;41:323-330.
7. Kimura Y, Akihisa T, Yuasa N, Ukiya M, Suzuki T, Toriyama M, Motohashi S, Tokuda H: Cucurbitane-type triterpenoids from the fruit of Momordica charantia. J Nat Prod 2005;68:807-809. (Pubitemid 40825304)
8. Li QY, Chen HB, Liu ZM, Wang B, Zhao YY: Cucurbitane triterpenoids from Momordica charantia. Magn Reson Chem 2007;45:451-456.
9. Murakami T, Emoto A, Matsuda H, Yoshikawa M: Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem Pharm Bull 2001;49:54-63.
10. Nakamura S, Murakami T, Nakamura J, Kobayashi H, Matsuda H, Yoshikawa M: Structures of new cucurbitane-type triterpenes and glycosides, karavilagenins and karavilosides, from the dried fruit of Momordica charantia L. in Sri Lanka. Chem Pharm Bull 2006;54:1545-1550. (Pubitemid 44703980)
11. Ng TB, Wong CM, Li WW, Yeung HW: A steryl glycoside fraction from Momordica-Charantia seeds with an inhibitory-action on lipid-metabolism invitro. Biochem Cell Biol 1986;64:766-771. (Pubitemid 16028044)
12. Fatope MO, Takeda Y, Yamashita H, Okabe H, Yamauchi T: New cucurbitane triterpenoids from Momordica-Charantia. J Nat Prod 1990;53:1491-1497.
13. Chang CI, Chen CR, Liao YW, Cheng HL, Chen YC, Chou CH: Cucurbitane-type triterpenoids from the stems of Momordica charantia. J Nat Prod 2008;71:1327-1330.
14. Li QY, Liang H, Chen HB, Wang B, Zhao YY: A new cucurbitane triterpenoid from Momordica charantia. Chin Chem Lett 2007;18:843-845.
15. Williams G: Obesity and type 2 diabetes: a conflict of interests? Int J Obes 1999;23(Suppl 7):S2-S4.
16. Ahmed I, Adeghate E, Cummings E, Sharma AK, Singh J: Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol Cell Biochem 2004;261:63-70. (Pubitemid 39004517)
17. Sarkar S, Pranava M, Marita R: Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol Res 1996;33:1-4. (Pubitemid 26229602)
18. Chandra A, Mahdi AA, Ahmad S, Singh RK: Indian herbs result in hypoglycemic responses in streptozotocin-induced diabetic rats. Nutr Res 2007;27:161-168. (Pubitemid 46414038)
19. Rathi SS, Grover JK, Vats V: The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother Res 2002;16:236-243. (Pubitemid 34534949)
20. Shetty AK, Kumar GS, Sambaiah K, Salimath PV: Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats. Plant Foods Hum Nutr 2005;60:109-112. (Pubitemid 41413977)
21. Roffey BW, Atwal AS, Johns T, Kubow S: Water extracts from Momordica charantia increase glucose uptake and adiponectin secretion in 3T3-L1 adipose cells. J Ethnopharmacol 2007;112:77-84. (Pubitemid 46702417)
22. Chang MK, Conkerton EJ, Chapital DC, Wan PJ, Vadhwa OP, Spiers JM: Chinese melon (Momordica charantia L) seed: composition and potential use. J Am Oil Chem Soc 1996;73:263-265. (Pubitemid 126525466)
23. Zhang W, Yeo MC, Tang FY, Popovich DG: Bioactive responses of Hep-G2 cells to soyasaponin extracts differs with respect to extraction conditions. Food Chem Toxicol 2009;47:2202-2208.
24. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N: Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 1998;47:1562-1569. (Pubitemid 28445343)
25. Kobori M, Ohnishi-Kameyama M, Akimoto Y, Yukizaki C, Yoshida M: alpha-Eleostearic acid and its dihydroxy derivative are major apoptosis-inducing components of bitter gourd. J Agric Food Chem 2008;56:10515-10520.
26. Danpure CJ: Lactate dehydrogenase and cell injury. Cell Biochem Funct 1984;2:144-148.
27. Popovich DG, Kitts DD: Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch Biochem Biophys 2002;406:1-8. (Pubitemid 35191710)
28. Popovich DG, Kitts DD: Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells. J Biochem Mol Toxicol 2004;18:143-149. (Pubitemid 39069608)
29. Popovich DG, Kitts DD: Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2. Can. J Physiol Pharmacol. 2004;82:183-190. (Pubitemid 38621691)
30. Lui J, Zhang W, Jing H, Popovich DG: Bog bilberry (Vaccinium uliginosum L) extract reduces cultured Hep-G2, Caco-2 and 3T3-L1 cell viability, affects cell cycle progression and has variable effects on membrane permeability. J Food Sci 2010;75:H103-H107.
31. Fantinelli JC, Schinella G, Cingolani HE, Mosca SM: Effects of different fractions of a red wine non-alcoholic extract on ischemia-reperfusion injury. Life Sci 2005;76:2721-2733. (Pubitemid 40404059)
32. Veigas JM, Shrivasthava R, Neelwarne B: Efficient amelioration of carbon tetrachloride induced toxicity in isolated rat hepatocytes by Syzygium cumini Skeels extract. Toxicol In Vitro 2008;22:1440-1446.
33. Hakomori S: Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res 1985;45:2405-2414.
34. Bühler H, Perschel FH, Hierholzer K: Inhibition of rat renal 11beta-hydroxysteroid dehydrogenase by steroidal compounds and triterpenoids; structure=function relationship. Biochim Biophys Acta 1991;1075:206-212.
35. Camp HS, Ren D, Leff T: Adipogenesis and fat-cell function in obesity and diabetes. Trends Mol Med 2002;8:442-447. (Pubitemid 34975991)
36. Green H, Meuth M: An established pre-adipose cell line and its differentiation in culture. Cell 1974;3:127-133.
37. Gregoire FM, Smas CM, Sul HS: Understanding adipocyte differentiation. Physiol Rev 1998;78:783-809. (Pubitemid 28340604)
38. Gregoire FM: Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood) 2001;226:997-1002.
39. Kim KJ, Lee OH, Lee BY: Fucoidan, a sulfated polysaccharide, inhibits adipogenesis through the mitogen-activated protein kinase pathway in 3T3-L1 preadipocytes. Life Sci 2010;86:791-797.
40. Kubota H, Kojima-Yuasa A, Morii R, Huang X, Norikura T, Rho SN, Matsui-Yuasa I: Anti-obesity effect of Blumea balsamifera extract in 3T3-L1 preadipocytes and adipocytes. Am J Chin Med 2009;37:843-854.
41. Sung HY, Hong CG, Suh YS, Cho HC, Park JH, Bae JH, Park WK, Han J, Song DK: Role of (-)-epigallocatechin-3-gallate in cell viability, lipogenesis, and retinol-binding protein 4 expression in adipocytes. Naunyn Schmiedebergs Arch Pharmacol 2010;382:303-310.
42. Shimojo Y, Kosaka K, Shirasawa T: Effect of Ganoderma lucidum extract on adipocyte differentiation and adiponectin gene expression in the murine pre-adipocyte cell line, 3T3-L1. Phytother Res 2010 July 14 [Epub ahead of print].
43. Han KL, Jung MH, Sohn JH, Hwang JK: Ginsenoside 20S-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor gamma (PPARgamma) in 3T3-L1 adipocytes. Biol Pharm Bull 2006;29:110-113. (Pubitemid 43036705)
44. Hwang JT, Lee MS, Kim HJ, Sung MJ, Kim HY, Kim MS, Kwon DY: Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother Res 2009;23:262-266.
45. Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ, Kim MJ, Kim HS, Ha J, Kim MS, Kwon DY: Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem Biophys Res Commun 2007;364:1002-1008. (Pubitemid 350103699)